Get started
SANTEN PHARMACEUTICAL CO LTD SANTEN PHARMACEUTICAL CO LTD SANTEN PHARMACEUTICAL CO LTD

SANTEN PHARMACEUTICAL CO LTD

No trades
See on Supercharts
Overview
Financials News Ideas Minds Technicals Forecast

SZD chart

Upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats

Market capitalization
‪3.43 B‬EUR
Dividend yield (indicated)
2.14%
Price to earnings Ratio (TTM)
21.50
Basic EPS (TTM)
0.45EUR
Net income (FY)
‪163.09 M‬EUR
Revenue (FY)
‪1.85 B‬EUR
Shares float
‪319.49 M‬
Beta (1Y)
0.30

About SANTEN PHARMACEUTICAL CO

Sector
Health Technology
CEO
Takeshi Ito
Headquarters
Osaka
Website
santen.co.jp
Founded
2016
ISIN
JP3336000009
FIGI
Santen Pharmaceutical Co., Ltd engages in the manufacture and sale of pharmaceutical products and medical devices. It operates through the following segments: Pharmaceuticals and Others. The Pharmaceuticals segment includes prescription ophthalmic drugs, anti-rheumatic pharmaceuticals, and over-the-counter products. The Others segment offers medical equipment and devices. The company was founded by Kenkichi Tagushi in 1890 and is headquartered in Osaka, Japan.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of SZD is 9.40 EUR — it has increased by 0.53% in the past 24 hours. Watch SANTEN PHARMACEUTICAL CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange SANTEN PHARMACEUTICAL CO LTD stocks are traded under the ticker SZD.
SZD stock has fallen by 2.08% compared to the previous week, the month change is a 2.08% fall, over the last year SANTEN PHARMACEUTICAL CO LTD has showed a 9.94% increase.
We've gathered analysts' opinions on SANTEN PHARMACEUTICAL CO LTD future price: according to them, SZD price has a max estimate of 14.13 EUR and a min estimate of 8.83 EUR. Watch SZD chart and read a more detailed SANTEN PHARMACEUTICAL CO LTD stock forecast: see what analysts think of SANTEN PHARMACEUTICAL CO LTD and suggest that you do with its stocks.
SZD reached its all-time high on May 13, 2024 with the price of 9.75 EUR, and its all-time low was 8.20 EUR and was reached on Nov 7, 2023. View more price dynamics on SZD chart.
See other stocks reaching their highest and lowest prices.
SZD stock is 0.53% volatile and has beta coefficient of 0.30. Track SANTEN PHARMACEUTICAL CO LTD stock price on the chart and check out the list of the most volatile stocks — is SANTEN PHARMACEUTICAL CO LTD there?
Today SANTEN PHARMACEUTICAL CO LTD has the market capitalization of ‪3.43 B‬, it has decreased by 1.62% over the last week.
Yes, you can track SANTEN PHARMACEUTICAL CO LTD financials in yearly and quarterly reports right on TradingView.
SANTEN PHARMACEUTICAL CO LTD is going to release the next earnings report on Aug 6, 2024. Keep track of upcoming events with our Earnings Calendar.
SZD earnings for the last quarter are 0.10 EUR per share, whereas the estimation was 0.11 EUR resulting in a −6.51% surprise. The estimated earnings for the next quarter are 0.13 EUR per share. See more details about SANTEN PHARMACEUTICAL CO LTD earnings.
SANTEN PHARMACEUTICAL CO LTD revenue for the last quarter amounts to ‪497.34 M‬ EUR, despite the estimated figure of ‪484.59 M‬ EUR. In the next quarter, revenue is expected to reach ‪410.59 M‬ EUR.
SZD net income for the last quarter is ‪183.70 K‬ EUR, while the quarter before that showed ‪47.05 M‬ EUR of net income which accounts for −99.61% change. Track more SANTEN PHARMACEUTICAL CO LTD financial stats to get the full picture.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SANTEN PHARMACEUTICAL CO LTD EBITDA is ‪431.52 M‬ EUR, and current EBITDA margin is 23.34%. See more stats in SANTEN PHARMACEUTICAL CO LTD financial statements.
Like other stocks, SZD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SANTEN PHARMACEUTICAL CO LTD stock right from TradingView charts — choose your broker and connect to your account.